The FDA has approved Sprycel (dasatinib) for use in the treatment of adults in all phases of chronic myeloid leukemia (CML) with resistance or intolerance to prior therapy including Gleevec.
Like Gleevec, Sprycel is very expensive. Gleevec can cost $35,000 dollars a year. The price of Sprycel, an oral medication, varies by dosage but the price is between $2,600 dollars and $6,500 dollars per month. I wish I could advise you on insurance coverage but that depends on your insurer. Please click here for payment assistance.